CDRE Cadre Holdings, Inc.

NYSE Orthopedic, Prosthetic & Surgical Appliances & Supplies DE CIK: 0001860543
AI RATING
SELL
72% Confidence

Investment Thesis

While Cadre Holdings demonstrates modest revenue growth (7.5%) and positive free cash flow generation, fundamental profitability metrics reveal severe operational challenges. The company's return on equity (0.6%) and return on assets (0.2%) are alarmingly low, indicating capital is being deployed with minimal efficiency. Most concerning, net income remained completely flat year-over-year despite revenue growth, signaling margin compression that raises questions about unit economics and operational leverage.

Strengths

  • + Positive free cash flow generation of $19.8M with 12.8% FCF margin indicating cash generation capability
  • + Adequate liquidity position with current ratio of 2.26x and quick ratio of 1.33x
  • + Stable gross margin of 38.7% appropriate for orthopedic/surgical supplies sector
  • + Consistent positive operating cash flow of $22.5M supports operational viability

Risks

  • ! Critically low return on equity (0.6%) and return on assets (0.2%) indicate severe capital inefficiency
  • ! Net income flat year-over-year despite 7.5% revenue growth indicates margin deterioration and cost pressures offsetting top-line gains
  • ! Operating margin of 4.8% is dangerously thin and leaves minimal buffer for operational disruptions
  • ! Elevated leverage at 1.04x debt-to-equity combined with weak profitability creates financial vulnerability
  • ! Net profit margin of 1.3% provides insufficient earnings cushion relative to debt servicing requirements

Key Metrics to Watch

Financial Metrics

Revenue
155.4M
Net Income
2.0M
EPS (Diluted)
$0.05
Free Cash Flow
19.8M
Total Assets
879.7M
Cash
41.3M

Profitability Ratios

Gross Margin 38.7%
Operating Margin 4.8%
Net Margin 1.3%
ROE 0.6%
ROA 0.2%
FCF Margin 12.8%

Balance Sheet & Liquidity

Current Ratio
2.26x
Quick Ratio
1.33x
Debt/Equity
1.04x
Debt/Assets
61.8%
Interest Coverage
4.58x
Long-term Debt
349.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-12T07:01:14.625405 | Data as of: 2026-03-31 | Powered by Claude AI